0 0 0
This online shop is using cookies to give you the best shopping experience. Thereby for example the session information or language setting are stored on your computer. Without cookies the range of the online shop's functionality is limited. If you don't agree, please click here.

Shear, Dodiuk-Gad Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions

Current and Future Trends

ISBN: 978-981-13-1488-9

Edition: 1st Ed.

Publication date: October 2018

Cover: Hardcover

Pages: 314 p.

Illustrations: 95 ill.

Publisher: Springer

Delivery times, dependent on availability and publisher: between 2 and 14 days from when you complete the order.

Description

  • Clear clinical scenarios help guide the reader to understand the science and treatment of cutaneous drug reactions
  • Special chapters on the pharmacology, immunology and genetics of cutaneous drug eruptions bring readers up-to-date knowledge and insights
  • Full colour clinical plates and schemata make drug reactions understandable and helpful to practitioners and patients
  • International regulatory innovations can lead the way to safer development and deployment of important treatments

This resource guides prescribers, pharmacists, and regulators with an update on the recent expansion of basic and clinical knowledge that forms a framework for understanding cutaneous reactions. This understanding will lead, in turn, to better outcomes and decisions in treatment and management, both in the clinic and in the life cycle of drug development.
The skin is a common target for adverse drug events and even mild rashes can be part of life-threatening syndromes. Patients and practitioners often face important decisions about therapy after a drug eruption, including treatment, cross-reactivity with future pharmaceuticals, genetic considerations and dealing with long-term sequelae after a reaction. An international team of experts and leaders in the field share their story and insights into the scientific details and relevant clinical context.